BioWorld MedTech

Oct. 15, 2010

Court Report: Medtronic to pay $268M to settle Sprint Fidelis suits

Medtronic (Minneapolis) said Thursday it will pay $268 million to settle U.S. lawsuits related to its Sprint Fidelis family of defibrillation leads which the company recalled three years ago. (Medical Device Daily) Read More

Washington roundup: FDA says it will rescind the controversial Menaflex 510(k)

Report from Europe: PneumRx gets CE mark for RePneu LVRC system

WellDoc, AT&T enter diabetes monitoring software partnership

Financings roundup: World Heart to raise $25.3M in private sale of common stock

MDD's food for med-tech thought

Agreements/contracts: Stöpler set to distribute QuikClot in the Netherlands

Grants roundup: Children's Hospital gets $1M for drug delivery device from NCI

Restructuring roundup: Baxter International creates new medical products business

New ventures: University of Minnesota spins off XO Thermix device startup

People in the News

Product Briefs

Wahlstrom to take over as LifeScience Alley CEO

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 27, 2024.

Illustration of neurons with Lewy bodies

Enhanced Cognition: Lewy body dementia phase II pumps stock

BioWorld

Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...

Experimental mRNA gene therapy suppresses preeclampsia in mice

BioWorld MedTech

A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...

Lab glassware and antibodies art concept

Probing bidirectional cancer-autoimmune link can yield new targets

BioWorld Science

Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...